Gary Krishnan
Company: Eli Lilly & Company
Job title: Senior Research Fellow Medical
Seminars:
Panel: Past, Present & Future Combinational Opportunities with JAKis 2:40 pm
Addressing the current dearth in certain disease profiles and speculating the use of combinational approaches for JAKi Highlighting the benefit of combinational approaches for targeted therapeutic treatments Discussing the current and future drug spectrum to highlight particular opportunitiesRead more
day: Day One
Speaker Q&A panel 1:25 pm
day: Day One
Cytokine Storm Implicates Use of Baricitinib in Hospitalized COVID-19 Patients 12:35 pm
Narrating Lilly’s fast- approval process for Baracitinib for pandemic application Addressing the MOA of a cytokine storm and effects this provides on JAKi use Potential anti-host anti-viral mechanism for Baricitinib and potential implicationsRead more
day: Day One